Form 4: Verastem Director Acquires 36,000 RSUs

Verastem, Inc. director Paul A. Bunn was granted 36,000 Restricted Stock Units (RSUs) on May 21, 2026, as part of the company's 2021 Equity Incentive Plan.

Summary

• Paul A. Bunn, a Director at Verastem, Inc., received a grant of 36,000 Restricted Stock Units (RSUs) on May 21, 2026.
• These RSUs are part of the company's Amended and Restated 2021 Equity Incentive Plan.
• Each RSU represents the contingent right to receive one share of Verastem's Common Stock.
• The RSUs will vest in twelve substantially equal installments, with the first eleven vesting monthly from June 2026 to April 2027.
• The final installment vests on the earlier of the day before the 2027 Annual Meeting of Stockholders or May 31, 2027.
• Vesting is contingent upon Mr. Bunn continuing to serve as a director on each respective vesting date.
• Following the grant, Mr. Bunn beneficially owns 44,333 shares of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity grant to a director and does not contain new financial performance data or strategic shifts.

Positives

• Director compensation through equity awards aligns management interests with shareholders.
• The grant of RSUs indicates continued confidence in the company's future prospects by a key insider.
• The vesting schedule over approximately one year provides retention incentive for the director.

Negatives

• The filing does not contain any negative information.

Risks

• The value of the RSUs is subject to the future performance of Verastem's stock price.
• Vesting is contingent on continued service, meaning the director could forfeit unvested RSUs if they depart the company before the vesting dates.

Future Outlook

The vesting schedule for the RSUs extends through May 2027, indicating a forward-looking compensation structure tied to continued service and company performance.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice in the biotechnology and pharmaceutical sectors, aligning executive incentives with long-term value creation and shareholder interests.

Stakeholder Impact

• Shareholders: The grant aligns director incentives with shareholder value, as the RSUs are tied to the company's stock performance. It also represents a non-cash compensation expense.
• Employees: The existence of an equity incentive plan signals a culture of rewarding key personnel, which can impact employee morale and retention.
• Management: The director receives equity compensation, which is a common form of remuneration.

Next Steps

• Vesting of RSUs according to the specified schedule, contingent on continued service.
• Potential future filings related to further equity transactions or changes in beneficial ownership.

Key Dates

Keywords

Verastem, VSTM, Form 4, Insider Trading, Restricted Stock Units, RSU Grant, Equity Incentive Plan, Director Compensation, Beneficial Ownership, SEC Filing